Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera); Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy (Dr. Di Donna).
Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera).
J Minim Invasive Gynecol. 2022 Sep;29(9):1083-1091. doi: 10.1016/j.jmig.2022.05.016. Epub 2022 May 29.
Resection of bulky lymph nodes in gynecologic oncology is a challenging procedure. Considering the risk of intraoperative vascular injury, a technique to avoid severe complications is mandatory. In this study, we aimed to analyze the feasibility of laparoscopic ultraradical lymph node debulking using Yasargil clamps in patients with gynecologic cancer with bulky lymph node metastases.
Multicenter retrospective case series (ClinicalTrialg.gov ID: NCT05318170), between September 2010 and April 2020.
Units of Gynecologic Oncology.
Patients with gynecologic cancer with bulky lymph node metastases.
Laparoscopic ultraradical lymph node debulking using Yasargil clamps.
Forty-three patients with gynecologic cancer with bulky pelvic and/or aortic lymph nodes metastases undergoing laparoscopic lymph node debulking surgery using Yasargil clamps were included. Median surgical time was 300 minutes (range, 120-550 minutes); median estimated blood loss was 170 mL (range, 0-700 mL). Median size of lymph nodes was 50 mm (range, 25-100). R0 resection was achieved in all cases. Four intraoperative complications (9.3%) occurred. No conversion to open surgery was required. There were 8 postoperative complications, classified grade 2 or worse. There were no cases with intra- or postoperative mortality.
In our experience, in carefully selected patients with gynecologic cancer with bulky lymph nodes, laparoscopic lymph node debulking using Yasargil clamps could be considered a valid option to avoid potential severe vascular intraoperative complications.
妇科肿瘤学中大块淋巴结切除术是一项具有挑战性的操作。考虑到术中血管损伤的风险,必须采用一种避免严重并发症的技术。本研究旨在分析使用 Yasargil 夹行腹腔镜超根治性淋巴结去瘤术治疗妇科恶性肿瘤大块淋巴结转移患者的可行性。
多中心回顾性病例系列研究(ClinicalTrials.gov 注册号:NCT05318170),研究时间为 2010 年 9 月至 2020 年 4 月。
妇科肿瘤学单位。
妇科恶性肿瘤大块盆腔和/或主动脉淋巴结转移患者。
使用 Yasargil 夹行腹腔镜超根治性淋巴结去瘤术。
共纳入 43 例接受腹腔镜 Yasargil 夹淋巴结去瘤术治疗的妇科恶性肿瘤大块盆腔和/或主动脉淋巴结转移患者。中位手术时间为 300 分钟(范围 120-550 分钟);中位估计出血量为 170 mL(范围 0-700 mL)。中位淋巴结大小为 50 mm(范围 25-100)。所有病例均达到 R0 切除。术中发生 4 例并发症(9.3%)。无一例转为开放性手术。术后发生 8 例并发症,分级 2 级或更差。无术中或术后死亡病例。
在我们的经验中,在仔细选择的妇科恶性肿瘤大块淋巴结转移患者中,使用 Yasargil 夹行腹腔镜淋巴结去瘤术可被视为避免潜在严重血管术中并发症的有效选择。